NCT01292811

Brief Summary

The objective of this research program is to conduct a multi-site clinical randomized control trial that will evaluate the efficacy of functional electrical stimulation based upper limb intervention for people with tetraplegia. This will involve recruiting 84 persons with sub-acute tetraplegia across four sites (Montreal,Toronto, Fredericton and Edmonton) and will serve to evaluate three new Canadian hand function assessments that have been specifically developed for persons with tetraplegia. Although these assessments have been recently tested and have shown considerable promise, further evaluation on their clinical utility (in particular their responsiveness and validity) is required. As well, they need to be compared with one another to determine whether any of these tests is more appropriate for clinical applications or whether further test reduction or augmentation may be required. Having measures that are sensitive and accurate in assessing hand function is key for systematically evaluating emerging therapeutic interventions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 7, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 10, 2011

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 3, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2014

Completed
Last Updated

September 30, 2021

Status Verified

September 1, 2021

Enrollment Period

3.9 years

First QC Date

February 7, 2011

Last Update Submit

September 23, 2021

Conditions

Keywords

Spinal Cord InjuryFunctional Electrical StimulationHand functionTetraplegia

Outcome Measures

Primary Outcomes (1)

  • Functional Independence Measure to measure burden of care

    The FIM is an 18-item ordinal scale, used with all diagnoses within a rehabilitation population. It is viewed as the most useful tool for the assessment of progress during inpatient rehabilitation, and measures independent performance in self-care, sphincter control, transfers, locomotion, communication, and social cognition. By adding the points for each item, the possible total score ranges from 18 (lowest) to 126 (highest) level of independence

    Change from baseline at 8 weeks and at 6 month follow up

Secondary Outcomes (6)

  • Graded Redefined Assessment of Strength Sensibility and Prehension to assess gross motor function and sensation of the hand

    Change from basline upon completion of therapy (8 weeks)and at 6 month follow

  • Jamar® Hydraulic Hand Dynamometer to measure grip and pinch force

    Change from Baseline at 8 weeks and 6 months

  • Action Research Arm Test to measure upper extremity function

    Change from Baseline at 8 weeks and 6 months

  • Toronto Rehab Hand Function Test (TR-HFT)to measure gross motor hand function

    Change from Baseline at 8 weeks and 6 months

  • REJOYCE

    Change from Baseline at 8 weeks and 6 months

  • +1 more secondary outcomes

Study Arms (2)

Functional electrical Stimulation

EXPERIMENTAL

The functional electrical stimulation for the treatment group will begin by designing a stimulation protocol that can generate the palmar and/or the lateral grasp on demand. In other words, the stimulation sequence (protocol) will be developed for each patient individually using either Compex Motion or HEWHS stimulator; this will allow the patient, who otherwise cannot grasp, to do so with the system. Both stimulators will be used to deliver the same FES therapy. Stimulation parameters are: 1) balanced, biphasic, current regulated electrical pulses; 2) pulse amplitude from 8 to 50 mA (typical values 17-26 mA); 3) pulse width from 250 to 300 μs; and 4) pulse frequency from 20 to 70 Hz (typical value 25 to 40 Hz).

Device: Functional Electrical Stimulation (Compex Motion Stimulator)

Control Group

OTHER

The Control group will receive conventional occupational therapy pertaining to hand function \[15\]. The conventional therapy represents control activities against which the FES therapy will be assessed. The conventional occupational therapy includes: a) muscle facilitation exercises emphasizing the neurodevelopmental treatment approach; b) task-specific, repetitive functional training; c) strengthening and motor control training using resistance to available arm motion to increase strength; d) stretching exercises; e) electrical stimulation applied primarily for muscle strengthening (this is not FES but TENS application); f) activities of daily living including self-care where the upper limb was used as an assist if appropriate; and g) caregiver training.

Other: Conventional Occupational therapy

Interventions

Functional electrical Stimulation:Parameters of stimulation: 1) balanced, biphasic, current regulated electrical pulses; 2) pulse amplitude from 8 to 50 mA (typical values 17-26 mA); 3) pulse width from250 to 300 μs; and 4) pulse frequency from 20 to 70 Hz (typical value 25 to 40 Hz).

Also known as: Functional Electrical Stimulation
Functional electrical Stimulation

The Control group will receive conventional occupational therapy pertaining to hand function \[15\]. The conventional therapy represents control activities against which the FES therapy will be assessed. The conventional occupational therapy includes: a) muscle facilitation exercises emphasizing the neurodevelopmental treatment approach; b) task-specific, repetitive functional training; c) strengthening and motor control training using resistance to available arm motion to increase strength; d) stretching exercises; e) electrical stimulation applied primarily for muscle strengthening (this is not FES but TENS application); f) activities of daily living including self-care where the upper limb was used as an assist if appropriate; and g) caregiver training.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sustained a traumatic incomplete SCI between C4 and C7 levels
  • years of age or older
  • Less than 6 months post injury
  • Unable to grasp objects
  • Participants must have functional biceps and deltoid muscle strength which allows them to place their hand in the working space in front of themselves, i.e., at least a grade 3 on manual muscle testing
  • Participants should have a clear understanding of the goal of the study, which is to compare the FES technology to conventional occupational therapy (which may or may not enhance recovery)
  • Participants should be able to read and understand and provide informed consent, and in a situation where there is a difficulty in understanding ( e.g. language barrier), have a relative or friend willing and able to accompany you to all treatment and assessment sessions, for your own safety

You may not qualify if:

  • Contraindications for FES:
  • cardiac pacemakers
  • skin lesions, allergy, wound or rash at potential electrode sites
  • denervation of targeted muscles
  • pressure ulcers
  • patient suffers from the cardiovascular conditions such as hypertension that is uncontrolled or autonomic dysreflexia requiring medication
  • Patients on Botox therapy for their upper limb or have received Botox for the upper extremity in the last six months
  • Participation in any other interventional study that may affect upper extremity function
  • Participants with co existing Traumatic brain injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto Rehabilitation Institute

Toronto, Ontario, M4G 3V9, Canada

Location

MeSH Terms

Conditions

Spinal Cord InjuriesQuadriplegia

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dr. Milos R Popovic, PhD

    Toronto Rehabilitation Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Toronto Rehab Chair in Spinal Cord Injury Research

Study Record Dates

First Submitted

February 7, 2011

First Posted

February 10, 2011

Study Start

January 1, 2011

Primary Completion

December 3, 2014

Study Completion

December 3, 2014

Last Updated

September 30, 2021

Record last verified: 2021-09

Locations